# Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engager

> **Open Intelligence Dossier** · First detected: 2026-10-02 18:00 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engager" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Bloomberg.com, CNBC, Axios and Reuters. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Bloomberg.com | Novartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxORlo2VnlsZVRFdVp0d3hNa2d6QnZkR2RIcWI1OGpCa2VWaWFycXZQM0V6eGZkSkNMeThMbU05UW5HdldvdUdacHpzNXNQMkpkM19EN09HRXg1ZWljaXdTa1ZmWXVSUVVmb2ZCNEw5a3VKa0FtUFdUR2dsZDhtTjNMZjBLQ1hfYkF2V0RUb3ExbHhwSWMwSE5MNl9iZ3JQb0JnNENPZ3R3SnVMQTVMd1llTTR3?oc=5) |
| CNBC | Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion | [Source Link](https://news.google.com/rss/articles/CBMie0FVX3lxTE9QYm51cUFUM2dqNUhwM203ekVWOWVsblB5Y3AtZHYyWGx2bTFjMWpNU3Y0U0UxN1NHSk5GMllabWxLdjBiRDBJLThtZEM4Z3ZGWkRDSlhOQ1BjZzVNMTVicFRLQ3VJVGhlZHJTOUh6d2p5YXVObHVkdGJZQdIBgAFBVV95cUxNUWVtRDEyZUNXM1pEdm9oU1E2TzI4TXV2bktEaHo5ZnhVMHJiNXBKUFJYVC02b0hFWWxHQnBscDhYay1TSTE0RC05WHUyRDFoS2xPaXJqSG5TLWFsUUNKT0NGS0tLa3VWMEFzQkFTNm1taGdVbk5qZUhuQ3hOZU9UVw?oc=5) |
| Axios | Novartis signs $7.8 billion drug deal with Chinese startup | [Source Link](https://news.google.com/rss/articles/CBMiYkFVX3lxTE1pZ3JZOFhVLTEyemswLXk5UGFUMjlNdWhhT3R5LTlIQ2VmRDBxZmlnVDRrSXZ1WDlHMzE4MDFYY29XSmRqUmltRnhvX2NoT0ZsV2Q2ZjlERkVtQ0xfMzZVQzln?oc=5) |
| Reuters | Novartis strikes up to $7.8 billion mRNA deal with China's Abogen | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxNZWh5dEJ1LTdGU0pVQkdPODNVU2YybE5ielZvYkMyLTFnZWtxSU8xR21hXzVCVVhNb3NlQ3VIVnRqUFNZdjZNVjgtOHQybGNDTmlsVllPSWxoQ3B2WVN6Y3lxVHJ1ZDFKSi1jVktDbm84Zk9vSGtVVGNXUmNIektOYkN4azBxanNsbThzNTRCUGdQQ2lpbG9Zb19hSEpjbWdrVXpoSDV1b2NUNXZ6ZTA1MzhiTTN0QQ?oc=5) |
| fiercebiotech.com | Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engager | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxOdzFFVmNSUENDSVN2WnRTZjhFc3Q3M0ZQZjJHTG42Zk9vRFZkVl9NQmptQXhMSVVKSmE2TTRweXlGWFJGVl9Ca0U4YzVlQncxSjRFejlVdlBZLUtOMzdPRWV4ZFRaaXB3R3RvbnV2X3pPd3NUUUV5cHpqQXJ6UUFuangyWXJMdGtYYU5qdkxCNFFHXzVLcW1ndjZB?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-10-02/novartis-pens-7-8b-deal-for-abogen-s-in-vivo-autoimmune-t-cell-engager*